Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05459922 · ClinicalTrials.gov registry record · NA
Adjunctive Bright Light Therapy for Opioid Use Disorder
A NA study of Opioid Use Disorder and Sleep Disturbance, sponsored by Arizona State University.
- Recruiting
- Registry status
- NA
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT05459922 is a NA study of Opioid Use Disorder and Sleep Disturbance that is actively recruiting participants, run by Arizona State University. The registered enrollment target is 23 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05459922, a NA study of Opioid Use Disorder and Sleep Disturbance, is actively recruiting participants, sponsored by Arizona State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators propose to conduct a pilot single-blind, parallel arm, randomized placebo-controlled trial evaluating the feasibility, acceptability, and preliminary efficacy of bright light therapy on reward system functioning among patients undergoing medication-assisted treatment for opioid use disorder.
Conditions Studied
Interventions
- DEVICE Wearable bright light therapy device
- DEVICE Wearable placebo light therapy device
Study Locations (1)
Arizona
- Arizona State University - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2022-10-23 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05459922
The ClinicalTrials.gov registry entry for NCT05459922 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (100% lower). The listed sponsor is Arizona State University, which has 187 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Wearable bright light therapy device is the first listed.
NCT05459922 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT05459922 about?
NCT05459922 is a clinical study titled "Adjunctive Bright Light Therapy for Opioid Use Disorder". Investigators propose to conduct a pilot single-blind, parallel arm, randomized placebo-controlled trial evaluating the feasibility, acceptability, and preliminary efficacy of bright light therapy on reward system functioning among patients undergoing medication-assisted treatment for opioid use dis...
What is the current status of trial NCT05459922?
This trial is currently recruiting. It is a NA study. The enrollment target is 23 participants. The study started on 2022-10-23. Estimated completion is 2026-05-31.
What conditions does trial NCT05459922 study?
This clinical trial studies the following conditions: Opioid Use Disorder, Sleep Disturbance.
What interventions are being tested in trial NCT05459922?
The interventions under investigation include: Wearable bright light therapy device (DEVICE), Wearable placebo light therapy device (DEVICE).
Who is sponsoring clinical trial NCT05459922?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05459922 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.